Vmware (VMW) Shareholder Gillespie Robinson & Grimm Has Boosted Holding; As Merck & Co New Com (MRK) Market Value Declined, Boston Advisors Lowered Stake

February 13, 2018 - By Dolores Ford

Boston Advisors Llc decreased its stake in Merck & Co Inc New Com (MRK) by 6.56% based on its latest 2017Q3 regulatory filing with the SEC. Boston Advisors Llc sold 24,275 shares as the company’s stock declined 2.46% while stock markets rallied. The institutional investor held 345,690 shares of the health care company at the end of 2017Q3, valued at $22.14M, down from 369,965 at the end of the previous reported quarter. Boston Advisors Llc who had been investing in Merck & Co Inc New Com for a number of months, seems to be less bullish one the $150.25B market cap company. The stock decreased 0.51% or $0.28 during the last trading session, reaching $55.15. About 1.35 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since February 13, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Gillespie Robinson & Grimm Inc increased its stake in Vmware Inc. (VMW) by 2.25% based on its latest 2017Q3 regulatory filing with the SEC. Gillespie Robinson & Grimm Inc bought 5,700 shares as the company’s stock rose 1.43% with the market. The institutional investor held 259,509 shares of the technology company at the end of 2017Q3, valued at $28.34 million, up from 253,809 at the end of the previous reported quarter. Gillespie Robinson & Grimm Inc who had been investing in Vmware Inc. for a number of months, seems to be bullish on the $47.18B market cap company. The stock increased 0.38% or $0.44 during the last trading session, reaching $117.02. About 299,172 shares traded. VMware, Inc. (NYSE:VMW) has risen 57.35% since February 13, 2017 and is uptrending. It has outperformed by 40.65% the S&P500.

Since September 1, 2017, it had 0 insider purchases, and 7 selling transactions for $7.02 million activity. Raghuram Rangarajan (Raghu) also sold $2.82M worth of VMware, Inc. (NYSE:VMW) shares. On Friday, December 8 POONEN SANJAY sold $327,534 worth of VMware, Inc. (NYSE:VMW) or 2,764 shares. Shares for $646,920 were sold by Rowe Zane. Shares for $1.48 million were sold by Krysler P. Kevan.

Investors sentiment increased to 1.22 in Q3 2017. Its up 0.01, from 1.21 in 2017Q2. It increased, as 42 investors sold VMW shares while 122 reduced holdings. 62 funds opened positions while 138 raised stakes. 87.77 million shares or 1.59% more from 86.40 million shares in 2017Q2 were reported. L And S Advsr has 0.57% invested in VMware, Inc. (NYSE:VMW) for 31,303 shares. Hanseatic reported 6,618 shares. Holderness Investments Com holds 2,800 shares or 0.16% of its portfolio. Cap World Invsts reported 0.08% stake. Convergence Invest Partners Limited Liability has 21,019 shares for 0.33% of their portfolio. Nine Chapters Capital Mgmt Limited Liability Company accumulated 6,200 shares. Oppenheimer Asset Mgmt reported 0% of its portfolio in VMware, Inc. (NYSE:VMW). Kbc Group Inc Nv reported 0.54% stake. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0.1% in VMware, Inc. (NYSE:VMW). Invesco holds 418,306 shares or 0.02% of its portfolio. Schroder Investment Mgmt Group has 0.07% invested in VMware, Inc. (NYSE:VMW). Massachusetts Communications Ma holds 0% of its portfolio in VMware, Inc. (NYSE:VMW) for 31,538 shares. Moreover, Commercial Bank Of Mellon has 0.02% invested in VMware, Inc. (NYSE:VMW) for 598,296 shares. Alexandria Capital Ltd Liability Co holds 0% or 42 shares in its portfolio. Twin Mngmt holds 0.18% of its portfolio in VMware, Inc. (NYSE:VMW) for 32,097 shares.

Among 46 analysts covering VMware Inc (NYSE:VMW), 21 have Buy rating, 1 Sell and 24 Hold. Therefore 46% are positive. VMware Inc had 165 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Buy” rating by Oppenheimer on Friday, June 2. Evercore reinitiated the stock with “Hold” rating in Monday, October 31 report. Monness Crespi & Hardt maintained it with “Buy” rating and $95 target in Monday, October 12 report. The firm earned “Buy” rating on Monday, January 29 by Deutsche Bank. The stock of VMware, Inc. (NYSE:VMW) has “Neutral” rating given on Wednesday, October 21 by Atlantic Securities. The stock of VMware, Inc. (NYSE:VMW) earned “Neutral” rating by Susquehanna on Wednesday, October 21. The stock of VMware, Inc. (NYSE:VMW) has “Buy” rating given on Thursday, August 31 by Robert W. Baird. Drexel maintained the shares of VMW in report on Wednesday, October 21 with “Hold” rating. On Monday, November 6 the stock rating was maintained by Barclays Capital with “Overweight”. Jefferies maintained the stock with “Buy” rating in Tuesday, September 26 report.

Gillespie Robinson & Grimm Inc, which manages about $954.83 million and $750.30 million US Long portfolio, decreased its stake in Eaton Corp Plc (NYSE:ETN) by 12,025 shares to 301,172 shares, valued at $23.13M in 2017Q3, according to the filing. It also reduced its holding in Anadarko Petroleum (NYSE:APC) by 6,675 shares in the quarter, leaving it with 59,965 shares, and cut its stake in Facebook Inc. (NASDAQ:FB).

Boston Advisors Llc, which manages about $2.55B and $4.42 billion US Long portfolio, upped its stake in Southwest Gas Corp Com (NYSE:SWX) by 22,140 shares to 75,967 shares, valued at $5.90M in 2017Q3, according to the filing. It also increased its holding in National Storage Affiliates by 59,415 shares in the quarter, for a total of 204,245 shares, and has risen its stake in Novartis A G Sponsored Adr (NYSE:NVS).

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 16 have Buy rating, 0 Sell and 7 Hold. Therefore 70% are positive. Merck & Co. Inc. had 76 analyst reports since August 13, 2015 according to SRatingsIntel. The rating was maintained by Deutsche Bank on Monday, July 17 with “Hold”. Citigroup upgraded the stock to “Buy” rating in Wednesday, October 18 report. The firm has “Buy” rating by BMO Capital Markets given on Monday, June 12. The rating was maintained by Leerink Swann with “Market Perform” on Monday, October 30. The stock of Merck & Co., Inc. (NYSE:MRK) has “Market Perform” rating given on Tuesday, February 6 by Leerink Swann. As per Friday, January 13, the company rating was initiated by Bryan Garnier & Cie. The rating was upgraded by Barclays Capital on Tuesday, December 1 to “Overweight”. The company was maintained on Tuesday, June 6 by BMO Capital Markets. Piper Jaffray maintained Merck & Co., Inc. (NYSE:MRK) rating on Thursday, October 26. Piper Jaffray has “Buy” rating and $70.0 target. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Tuesday, November 24 by Berenberg.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It dropped, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Broderick Brian C owns 35,944 shares. First Washington Corporation has invested 0.02% in Merck & Co., Inc. (NYSE:MRK). Noesis Capital Mangement Corp has invested 0.44% in Merck & Co., Inc. (NYSE:MRK). Bancorp Of Nova Scotia Trust accumulated 0.26% or 38,403 shares. Hillsdale Investment Management, a Ontario – Canada-based fund reported 5,800 shares. Independent Franchise Prtnrs Llp reported 9.66 million shares. Apriem Advsr holds 8,248 shares. Susquehanna Limited Liability Partnership accumulated 752,303 shares. 51,973 are owned by Duncker Streett & Com. Trexquant Invest Lp has invested 0.2% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Baldwin Brothers Incorporated Ma holds 225,915 shares or 2.33% of its portfolio. Braun Stacey Assocs Inc accumulated 291,561 shares. Sumitomo Mitsui holds 7.98 million shares or 0.72% of its portfolio. Wafra Investment Advisory Ny, a New York-based fund reported 395,781 shares. Glenmede Tru Co Na accumulated 2.66 million shares.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>